Mainstay Medical is ready to launch its ReActiv8 neurostimulator, starting in Germany, now that the implantable device has a CE mark for the treatment of chronic back pain, the company announced May 25.
Mainstay has its own direct sales force that will focus on German hospitals that treat a large back-pain patient population...